As of January 2026 ArriVent BioPharma has a market cap of โน84.23 Billion. This makes ArriVent BioPharma the world's 6130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 20th, 2026 the market cap of ArriVent BioPharma was reported to be: